Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mabpharm Limited ( (HK:2181) ) has provided an update.
Mabpharm Limited has announced that its board of directors will meet on August 28, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will determine the company’s financial performance and could impact its market positioning and stakeholder interests.
More about Mabpharm Limited
Mabpharm Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and production of biopharmaceutical products.
Average Trading Volume: 530,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.72B
For a thorough assessment of 2181 stock, go to TipRanks’ Stock Analysis page.